Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019
Titel:
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019
Auteur:
Moscetti, L. Barbieri, E. Zattarin, E. Vici, P. Zoppoli, G. Musolino, A. Natalizio, S. Canino, F. Ravera, F. Filomeno, L. Arcuri, T. Omarini, C. Piacentini, F. Barbolini, M. Cortesi, L. Caggia, F. Civallero, M. Dominici, M. Toss, A.